Reuters logo
3 months ago
BRIEF-Shire expects to file potential EU marketing submission for lanadelumab in H1 2018
May 18, 2017 / 2:44 PM / 3 months ago

BRIEF-Shire expects to file potential EU marketing submission for lanadelumab in H1 2018

May 18 (Reuters) - Shire Plc-

* Shire says potential EU marketing submission for lanadelumab is expected to be filed in first half of 2018, pending discussion with the EMA

* Shire CEO does not comment on potential lanadelumab pricing Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below